On Invalid Date, Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q4 2023 earnings per share (EPS) of -$0.11, up 26.67% year over year. Total Anebulo Pharmaceuticals earnings for the quarter were -$2.72 million. In the same quarter last year, Anebulo Pharmaceuticals's earnings per share (EPS) was -$0.15.
As of Q1 2024, Anebulo Pharmaceuticals's earnings has grown year over year. Anebulo Pharmaceuticals's earnings in the past year totalled -$10.49 million.
What is ANEB's earnings date?
Anebulo Pharmaceuticals's earnings date is Invalid Date. Add ANEB to your watchlist to be reminded of ANEB's next earnings announcement.
What was ANEB's revenue last quarter?
On Invalid Date, Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Anebulo Pharmaceuticals's revenue was $0.00.
What was ANEB's revenue growth in the past year?
As of Q1 2024, Anebulo Pharmaceuticals's revenue has grown null year over year. Anebulo Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.